APA (7th ed.) Citation

Weiss, L., Chevalier, M. F., Assoumou, L., Paul, J., Alhenc-Gelas, M., Didier, C., . . . Costagliola, D. (2016). Rosuvastatin Is Effective to Decrease CD8 T-Cell Activation Only in HIV-Infected Patients With High Residual T-Cell Activation Under Antiretroviral Therapy. JAIDS: Journal of Acquired Immune Deficiency Syndromes, 71(4), 390. https://doi.org/10.1097/QAI.0000000000000879

Chicago Style (17th ed.) Citation

Weiss, Laurence, et al. "Rosuvastatin Is Effective to Decrease CD8 T-Cell Activation Only in HIV-Infected Patients With High Residual T-Cell Activation Under Antiretroviral Therapy." JAIDS: Journal of Acquired Immune Deficiency Syndromes 71, no. 4 (2016): 390. https://doi.org/10.1097/QAI.0000000000000879.

MLA (9th ed.) Citation

Weiss, Laurence, et al. "Rosuvastatin Is Effective to Decrease CD8 T-Cell Activation Only in HIV-Infected Patients With High Residual T-Cell Activation Under Antiretroviral Therapy." JAIDS: Journal of Acquired Immune Deficiency Syndromes, vol. 71, no. 4, 2016, p. 390, https://doi.org/10.1097/QAI.0000000000000879.